Our study demonstrates that increased RBC deformability is associated with osteonecrosis in SCA. Irregularly shaped, deformable sickle RBC were previously shown to be more adherent than rigid, irreversibly sickle RBC, 7 hence triggering vascular occlusion. 8 The greater RBC deformability found in the OST+ group is probably due to the greater frequency of -thalassemia patients in this group since patients with -thalassemia had greater RBC deformability (0.18±0.05) than patients without (0.15±0.06, p<0.05). Even though higher Hb levels were observed in patients with osteonecrosis, the data do not support a significant role for blood viscosity in the pathogenesis of this complication, even after excluding data from patients under HU therapy. Further studies will be required to delineate the mechanisms by which RBC deformability raise the risk for osteonecrosis.
The pathogenesis of osteonecrosis in sickle cell anemia (SCA) remains unknown. Blood hyper-viscosity has been suggested as a factor involved in the genesis of osteonecrosis 1 , but not studied until now. We hypothesized that abnormal hemorheology could play a role in this complication. Hematological and hemorheological parameters were assessed in SCA patients with osteonecrosis (OST+, n=30) or without (OST-, n=67). Osteonecrosis was diagnosed as previously described 2 . The study was conducted according to the Declaration of Helsinki guidelines, and was approved by the Regional Ethics Committee. The results are reported in the table. OST+ patients were older than OST-(p < 0.05) and more had a history of vasoocclusive crises (VOC) within the previous year (p < 0.05) and a higher frequency of -thalassemia (p < 0.05), confirming previous studies [3] [4] [5] . Although the OST+ group exhibited higher Hb and Hct, and lower hemolytic component than the OST-group (p < 0.01), blood viscosity was not significantly different between the two groups (p < 0.20). In contrast, red blood cell (RBC) deformability (p < 0.001) and aggregation (p < 0.05) were increased in the OST+ group. The hydroxyurea (HU) treatment frequency was not significantly different between the two groups (p < 0.20). As HU is known to modulate RBC deformability 6 , we analyzed the data as a function of HU therapy independently of osteonecrosis, and found that HU-treated patients had lower blood viscosity and greater RBC deformability (data not shown). Excluding HU-treated patients from the cohort did not change the results (table). A binary (OST-/OST+) multivariate logistic model was used to identify factors associated with osteonecrosis in SCA patients, and included age, Hb, RBC aggregation and deformability, hemolytic component, -thalassemia status and previous history of VOC as covariates. The overall model was significant (chi-square=30.192; df=7; p<0.0001), and retained age (OR: 1.06; 95% CI 1.01-1.12; p<0.05), Hb (OR: 2.24; 95% CI 1.19-4.18; p<0.05) and RBC deformability (OR: 1.15; CI 1.01-1.33; p<0.05) as independent factors statistically associated with osteonecrosis. Two other binary multivariate logistic models were tested; one included the previous parameters plus blood viscosity and HU therapy, and the other excluded all HU patients. The results were similar to those in the first model (data not shown).
Our study demonstrates that increased RBC deformability is associated with osteonecrosis in SCA. Irregularly shaped, deformable sickle RBC were previously shown to be more adherent than rigid, irreversibly sickle RBC, 7 hence triggering vascular occlusion. 8 The greater RBC deformability found in the OST+ group is probably due to the greater frequency of -thalassemia patients in this group since patients with -thalassemia had greater RBC deformability (0.18±0.05) than patients without (0.15±0.06, p<0.05). Even though higher Hb levels were observed in patients with osteonecrosis, the data do not support a significant role for blood viscosity in the pathogenesis of this complication, even after excluding data from patients under HU therapy. Further studies will be required to delineate the mechanisms by which RBC deformability raise the risk for osteonecrosis.
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